ADTX
Aditxt, Inc.NASDAQHealthcare$0.60-24.81%ClosedMarket Cap: $1,606
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
0.00
EV/EBITDA
0.01
DCF Value
$-474.52
FCF Yield
-1600379950.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
8.4%
Operating Margin
-612542.2%
Net Margin
-1349028.2%
ROE
-3061.4%
ROA
-261.0%
ROIC
-281.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.2M | 12.6% | $-19.56B | $-43.06B | $702.12 | — |
| FY 2025 | $3.2M | 8.4% | $-19.57B | $-43.10B | $-1,153.83 | — |
| Q3 2025 | $748.00 | -9026.1% | $-3.1M | $-24.0M | $-548.78 | — |
| Q2 2025 | $1.0K | -6761.2% | $-6.2M | $-7.3M | $-390.17 | — |
| Q1 2025 | $1.0K | 27.9% | $-5.6M | $-5.7M | $-917.00 | — |
| Q4 2024 | $3.2K | -2136.4% | $-5.7M | $-5.2M | $-4,554.46 | — |
| FY 2024 | $134.0K | -368.0% | $-27.9M | $-34.4M | $-346,053.00 | — |
| Q3 2024 | $6.9K | -6721.4% | $-4.7M | $-6.9M | $-3,137,682.00 | — |
| Q2 2024 | $44.3K | 47.8% | $-6.0M | $-7.5M | $-4.19 | — |
| Q1 2024 | $79.7K | 17.4% | $-11.5M | $-14.7M | $-88,733.30 | — |
| Q4 2023 | $81.3K | -251.6% | $-8.0M | $-11.0M | $-9,527,990.00 | — |
| FY 2023 | $645.2K | -17.3% | $-26.1M | $-32.4M | $-249,623.74 | — |